SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 1,200 call options on the stock. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
SIGA Technologies Stock Up 0.4 %
NASDAQ:SIGA opened at $5.10 on Thursday. The stock’s 50 day moving average price is $5.53 and its 200 day moving average price is $6.18. SIGA Technologies has a 52-week low of $4.73 and a 52-week high of $26.99. The company has a market capitalization of $363.48 million, a PE ratio of 11.09 and a beta of 0.76.
SIGA Technologies (NASDAQ:SIGA – Get Free Report) last posted its quarterly earnings results on Thursday, May 4th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $8.32 million during the quarter. SIGA Technologies had a net margin of 30.72% and a return on equity of 20.68%. As a group, sell-side analysts anticipate that SIGA Technologies will post 1.05 EPS for the current fiscal year.
SIGA Technologies Announces Dividend
Institutional Investors Weigh In On SIGA Technologies
A number of institutional investors have recently added to or reduced their stakes in SIGA. Point72 Middle East FZE bought a new stake in shares of SIGA Technologies in the 4th quarter worth about $27,000. Gladius Capital Management LP bought a new position in shares of SIGA Technologies in the fourth quarter valued at approximately $32,000. UBS Group AG boosted its holdings in shares of SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after acquiring an additional 1,070 shares in the last quarter. State of Wyoming boosted its holdings in SIGA Technologies by 104.6% during the fourth quarter. State of Wyoming now owns 12,219 shares of the company’s stock worth $90,000 after buying an additional 6,247 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of SIGA Technologies by 27.2% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 13,014 shares of the company’s stock valued at $96,000 after acquiring an additional 2,783 shares in the last quarter. Hedge funds and other institutional investors own 44.41% of the company’s stock.
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- Contrarian Play: Beyond Meat Is At An Inflection Point
- Alibaba Just Flashed Green, Very Green
- This Small Cap Stock Surged Over 100%
- The CPI Data Isn’t As Good As You Think It Is
- How to Invest in Gold and Silver
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
